Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C21H26N2O4.ClH |
| Molecular Weight | 406.903 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.COC1=CC=C(C=C1OC)[C@H](O)CN2CCN(CC2)C3=CC=CC=CC3=O
InChI
InChIKey=UIOUCVPFPQUSAS-FSRHSHDFSA-N
InChI=1S/C21H26N2O4.ClH/c1-26-20-9-8-16(14-21(20)27-2)19(25)15-22-10-12-23(13-11-22)17-6-4-3-5-7-18(17)24;/h3-9,14,19,25H,10-13,15H2,1-2H3;1H/t19-;/m1./s1
Ciladopa, is a troponylpiperazine derivative and dopamine agonist that has been shown to influence dopaminergic mechanisms in animals. Preclinical pharmacological studies have suggested that it has antiparkinsonian activity similar to that of bromocriptine but without many of the troublesome side effects. Unfortunately in some clinical trials no significant differences was found among the treatment groups and placebo.
CNS Activity
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: P14416 Gene ID: 1813.0 Gene Symbol: DRD2 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/3774130 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3606037
15 mg twice daily for 8 weeks
Route of Administration:
Oral
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL2110793
Created by
admin on Mon Mar 31 18:00:18 GMT 2025 , Edited by admin on Mon Mar 31 18:00:18 GMT 2025
|
PRIMARY | |||
|
11954350
Created by
admin on Mon Mar 31 18:00:18 GMT 2025 , Edited by admin on Mon Mar 31 18:00:18 GMT 2025
|
PRIMARY | |||
|
U-40
Created by
admin on Mon Mar 31 18:00:18 GMT 2025 , Edited by admin on Mon Mar 31 18:00:18 GMT 2025
|
PRIMARY | |||
|
C171776
Created by
admin on Mon Mar 31 18:00:18 GMT 2025 , Edited by admin on Mon Mar 31 18:00:18 GMT 2025
|
PRIMARY | |||
|
ASR1NR721I
Created by
admin on Mon Mar 31 18:00:18 GMT 2025 , Edited by admin on Mon Mar 31 18:00:18 GMT 2025
|
PRIMARY | |||
|
83529-09-3
Created by
admin on Mon Mar 31 18:00:18 GMT 2025 , Edited by admin on Mon Mar 31 18:00:18 GMT 2025
|
PRIMARY | |||
|
300000055333
Created by
admin on Mon Mar 31 18:00:18 GMT 2025 , Edited by admin on Mon Mar 31 18:00:18 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD